Form 4 · Filed Jul 21, 2026, 01:16 AM UTC
MDGL/MADRIGAL PHARMACEUTICALS, INC.
Sibold William John — President and CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
12 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | S | sell | 280 | $555 | $155,414 | 209,329 |
| Jul 20, 2026 | S | sell | 140 | $543 | $75,984 | 211,689 |
| Jul 20, 2026 | S | sell | 110 | $544 | $59,817 | 211,579 |
| Jul 20, 2026 | S | sell | 545 | $545 | $296,869 | 211,034 |
| Jul 20, 2026 | S | sell | 275 | $546 | $150,070 | 210,759 |
| Jul 20, 2026 | S | sell | 269 | $547 | $147,164 | 210,490 |
| Jul 20, 2026 | S | sell | 680 | $548 | $372,435 | 209,810 |
| Jul 20, 2026 | S | sell | 47 | $549 | $25,797 | 209,763 |
| Jul 20, 2026 | S | sell | 153 | $550 | $84,152 | 209,610 |
| Jul 20, 2026 | S | sell | 1 | $551 | $551 | 209,609 |
| Jul 17, 2026 | M | other | 50,000 | — | — | 0 |
| Jul 17, 2026 | M | other | 50,000 | — | — | 211,829 |
Source: SEC EDGAR raw filing ↗ · Accession 0001628280-26-048919